Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 ...
CAMBRIDGE, Mass. & MONTREAL, November 07, 2024 -- ( BUSINESS WIRE )--Repare Therapeutics Inc. ("Repare" or the "Company") ...
Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update
Biotech industry leaders added to the Board of Directors, bringing deep expertise in drug discovery, neuroscience clinical development, and ...
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in ...
Submission of lead ADHD asset CTx-1301KANSAS CITY, Kan., Nov. 07, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: CING), a ...
EQS-News: Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate ...
NEW YORK, November 7, 2024 – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and ...
manilatimes36 分钟
LENSAR Reports Third Quarter 2024 Results and Provides Business Update
Installed system base grew 20% over third quarter of 2023 . ORLANDO, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- LENSAR ®, Inc. (Nasdaq: LNSR) ("LENSAR” or "the Company”), a glob ...